REWINKEL JOHANNES BERNARDUS MARIA
No ORCID on file
· 39 papers in corpus
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…
2010
Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein th…